| Autumn Ostlund, MS, CCC-SLP | |
|
615 Hamilton St, Douglas, WY 82633-2615 | |
| (307) 358-2942 | |
| Not Available |
| Full Name | Autumn Ostlund |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 615 Hamilton St, Douglas, Wyoming |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285371260 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SP-1124 (Wyoming) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Autumn Ostlund, MS, CCC-SLP 615 Hamilton St, Douglas, WY 82633-2615 Ph: () - | Autumn Ostlund, MS, CCC-SLP 615 Hamilton St, Douglas, WY 82633-2615 Ph: (307) 358-2942 |
News Archive
Cytori Therapeutics reported results from their preclinical study on the use of uncultured adipose-derived regenerative cells (ADRCs) in the treatment of critical periodontal defects in a rat model. The results suggest that the use of ADRCs may reverse the effects of periodontal disease, evidenced by significantly improved alveolar bone healing and decreased gingival (gum) invasion of the defect. The data were reported today at the 95th Annual Meeting of the American Academy of Periodontology in Boston.
Sartorius Stedim Biotech, a leading international supplier for the biopharmaceutical industry, has announced the ambr 15 automated micro bioreactor system combined with a Nova Biomedical BioProfile FLEX2 automated cell culture analyzer.
In the UK, more than 5% of emergency department visits and up to 40% of emergency admissions are as a direct result of chest pain. Chest pain-related emergency hospital admissions not only create a vast economic burden on healthcare services but also cause huge disruption to inpatient care.
Personal Genome Diagnostics, Inc., a leader in cancer genomics and pioneer in liquid biopsy, today reported that its non-invasive, pan-cancer plasma assay is being used in an important new clinical trial, Nivolumab, Ipilimumab in Patients With Hyper Mutated Cancers Detected in Blood, led by the Cancer Research Institute and Canadian Cancer Trials Group.
Biomet, Inc. announced today financial results for its third fiscal quarter ended February 28, 2010.
› Verified 2 days ago
Wyoming Child And Family Development, Inc. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 630 Erwin St, Douglas, WY 82633 Phone: 307-358-3901 | |
Jill M. Haskins, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 630 Erwin St, Douglas, WY 82633 Phone: 307-358-3901 | |
Dawn Sorg, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 615 Hamilton St, Douglas, WY 82633 Phone: 307-358-6187 | |
Brooke Varland, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1705 Hamilton St, Douglas, WY 82633 Phone: 307-359-0352 |